FDA releases analysis on drug product quality in 2022
There continues to be a correlation between low site inspection scores and potential drug recalls, states the US OPQ's 2022 annual report.
Stay updated with breaking news from Management Maturity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There continues to be a correlation between low site inspection scores and potential drug recalls, states the US OPQ's 2022 annual report.
The White Paper supports CDER’s long-held vision for pharmaceutical quality in the 21st century, described as a “maximally efficient, agile, flexible manufacturing sector” that is able to reliably produce high-quality drug products without extensive regulatory oversight.
The US Food and Drug Administration (FDA) Office of Pharmaceutical Quality (OPQ) of the Center for Drug Evaluation and Research (CDER) recently published a White Paper laying out a framework...
The US Food and Drug Administration (FDA) Office of Pharmaceutical Quality (OPQ) of the Center for Drug Evaluation and Research (CDER) recently published a White Paper laying out a...
Don't Let the Past Obstruct Your Zero Trust Future The surest way to slow Zero Trust adoption is making it dependent upon security that already isn't working. At the same time, we shouldn't ignore our strengths. I'm in awe of those who create the future free from the constraints of the present. Take Wells Coates, for example. In his day, high tech was music and news played from furniture, polished brass and wood that housed heavy electronics. I have a Brunswick phonograph from this time period that's larger than my desk. Coates reimagined what radio could be when he designed the Ekco AD-65. S...